Human monoclonal antibodies: the residual challenge of antibody immunogenicity.
One of the major reasons for seeking human monoclonal antibodies has been to eliminate immunogenicity seen with rodent antibodies. Thus far, there has yet been no approach which absolutely abolishes that risk for cell-binding antibodies. In this short article, I draw attention to classical work whic...
Main Author: | Waldmann, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody.
by: Routledge, E, et al.
Published: (1995) -
The immunogenicity of chimeric antibodies.
by: Brüggemann, M, et al.
Published: (1989) -
Humanized monoclonal antibody treatment in rheumatoid arthritis.
by: Kyle, V, et al.
Published: (1991) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
by: Isaacs, J, et al.
Published: (1992) -
Manipulation of T-cell responses with monoclonal antibodies.
by: Waldmann, H
Published: (1989)